The session aims to provide a comprehensive overview of the spatial omics technologies currently available for the discovery and validation of disease biomarkers. It will also serve as a platform to discuss the different analytical approaches used to interpret data generated from spatial omics analyses, highlighting methodological challenges, strengths, and future perspectives.